RT Journal Article
SR Electronic
T1 An emerging clade of Chikungunya West African genotype discovered in real-time during 2023 outbreak in Senegal
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.11.14.23298527
DO 10.1101/2023.11.14.23298527
A1 Padane, Abdou
A1 Tegally, Houriiyah
A1 Ramphal, Yajna
A1 Seyni, Ndiaye
A1 Sarr, Mariéma
A1 Diop, Mame Matar
A1 Diedhiou, Cyrille Kouligueul
A1 Mboup, Aminata
A1 Diouf, Ndèye Dieyna
A1 Souaré, Abdoulaye
A1 Diagne, Ndéye Diabou
A1 Aza-Gnandji, Marilyne
A1 Dabo, Ndèye Astou
A1 Dia, Yacine Amet
A1 Diaw, Ndeye Aminata
A1 Leye, Nafissatou
A1 Diaw, Papa Alassane
A1 Ahouidi, Ambroise
A1 Cissé, Badara
A1 Diallo, Abdoulaye Samba
A1 Diop, Ousmane
A1 Diallo, Abdou Aziz
A1 Ndoye, Souadou
A1 Sanko, Tomasz J.
A1 Baxter, Cheryl
A1 Wilkinson, Eduan
A1 San, James E.
A1 Tshabuila, Derek
A1 Naidoo, Yeshnee
A1 Pillay, Sureshnee
A1 Lessells, Richard
A1 Cissé, Khady
A1 Leye, Abdoulaye
A1 Mbaye, Khalifa Ababacar
A1 Kania, Dramane
A1 Tinto, Bachirou
A1 Traoré, Isidore
A1 Kagone, Sampawendé Thérèse
A1 Ouedraogo, Abdoul Salam
A1 Gifford, Robert J.
A1 Lourenço, José
A1 Giovanetti, Marta
A1 Giandhari, Jennifer
A1 de Oliveira, Tulio
A1 Mboup, Souleymane
YR 2023
UL http://medrxiv.org/content/early/2023/11/15/2023.11.14.23298527.abstract
AB Chikungunya (CHIKV) is a re-emerging endemic arbovirus in West Africa. Since July 2023, Senegal and Burkina Faso have been experiencing an ongoing outbreak, with over 300 confirmed cases detected so far in the regions of Kédougou and Tambacounda in Senegal, the largest recorded outbreak yet. CHIKV is typically maintained in a sylvatic cycle in Senegal but its evolution and factors contributing to re-emergence are so far unknown in West Africa, leaving a gap in understanding and responding to recurrent epidemics. We produced, in real-time, the first locally-generated and publicly available CHIKV whole genomes in West Africa, to characterize the genetic diversity of circulating strains, along with phylodynamic analysis to estimate time of emergence and population growth dynamics. A novel strain of the West African genotype, phylogenetically distinct from strains circulating in previous outbreaks, was identified. This suggests a likely new spillover from sylvatic cycles in rural Senegal and potential of seeding larger epidemics in urban settings in Senegal and elsewhere.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work has been supported by CLIMADE (Climate Amplified Diseases and Epidemics), the National Institute of Health USA (U01 AI151698) for the United World Antivirus Research Network (UWARN), Abbott Laboratories and by NIH NIAID U01AI151698, United World Antiviral Research Network, part of the NIAID CRIED network and WANETAM (West African Network in Tuberculosis AIDS and Malaria). Data analysis support was provided by the Centre for Epidemic Response and Innovation (CERI) at Stellenbosch University. Reagents for WGS were provided by CERI CLIMADE grant from the Rockefeller Foundation (HTH 017). The authors would like to express their gratitude to the Ministry of Health and to Drs. Mamadou Ndiaye, Boly Diop for their support. The authors would like to express their gratitude to the Kedougou District team particularly Dr Fode Danfakha for significant contribution and assistance during this project. The authors would like to express their recognition to the IRESSEF team and CERI group for their commitment during this project and the patients for their participation in this work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was reviewed and approved by the Comite National de Ethique pour la Recherche au Senegal (CNERS) (Ref. N 000031/MSAS/CNERS/SP/06/02/2023). All patients who provided consent to give samples for this study were enrolled and samples were collected by staff in the Kedougou district during the 2023 Chikungunya outbreak. The Direction de la Prevention, which is part of the Senegal Ministry of Health, was informed about IRESSEF intervention during Chikungunya outbreak in Senegal on August 8, 2023 with the reference number N/Ref: SM/IRESSEF/RARS/116.09.2023.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe resulting genomic sequences have been made available on GISAID Epi-Arbo database (EPI_ISL_18498014-EPI_ISL_18498039).